...
首页> 外文期刊>Journal of neurology >Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
【24h】

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

机译:Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Journal of neurology》 |2022年第12期|6690-6691|共2页
  • 作者单位

    Department NEUROFARBA,University of Florence;

    Department of Systems Medicine,Tor Vergata University;

    Department of Neuroscience,University of PadovaDepartment of Neurosciences,S Camillo Forlanini Hospital RomeDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child HealthDepartment GF Ingrassia, Medical, Surgical Science and Advanced Technologies,University of CataniaS. Andrea MS Center,Sapienza UniversityNeuroimaging Research Unit, Division of Neuroscience,IRCCS San Raffaele Scientific InstituteDepartment of Basic Medical Sciences, Neuroscience, and Sense Organs,University of Bari “Aldo Moro”;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 神经病学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号